Adriforant hydrochloride is primarily used in research settings to study its effects on the central nervous system, particularly in relation to cognitive functions and neurodegenerative disorders. It has shown potential in modulating specific receptors that play a role in memory and learning processes, making it a candidate for investigating therapeutic interventions for conditions like Alzheimer's disease. Additionally, it is explored for its possible applications in treating anxiety and depression due to its interaction with neurochemical pathways. Its use is largely confined to preclinical studies, where it helps in understanding the mechanisms of brain function and developing new pharmacological treatments.